I 
119TH CONGRESS 
1ST SESSION H. R. 6001 
To require the Secretary of Veterans Affairs to submit a report on risk 
reduction strategies to lower the incidence and prevalence of amyotrophic 
lateral sclerosis in veterans. 
IN THE HOUSE OF REPRESENTATIVES 
NOVEMBER 10, 2025 
Mr. CROW (for himself, Mr. CALVERT, Ms. SEWELL, and Mr. FITZPATRICK) 
introduced the following bill; which was referred to the Committee on 
Veterans’ Affairs 
A BILL 
To require the Secretary of Veterans Affairs to submit a 
report on risk reduction strategies to lower the incidence 
and prevalence of amyotrophic lateral sclerosis in vet-
erans. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Veterans with ALS 
Reporting Act’’. 
VerDate Sep 11 2014 
03:03 Nov 11, 2025
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6001.IH
H6001
kjohnson on DSK7ZCZBW3PROD with $$_JOB
SEC. 2. REPORT ON AMYOTROPHIC LATERAL SCLEROSIS IN 
VETERANS. 
(a) IN GENERAL.—Not later than one year after the 
date of the enactment of this Act, the Secretary of Vet-
erans Affairs, in consultation with the Director of the Cen-
ters for Disease Control and Prevention, shall submit to 
Congress a report on the incidence and prevalence of 
amyotrophic lateral sclerosis (commonly known as 
‘‘ALS’’). Such report shall include— 
(1) an assessment of the incidence and preva-
lence of amyotrophic lateral sclerosis in veterans (as 
defined in section 101 of title 38, United States 
Code); 
(2) a description of the resources and support 
that the the Centers for Disease Control and the De-
partment of Veterans Affairs provides to veterans 
with amyotrophic lateral sclerosis; 
(3) a description of any deficiencies in the re-
sources and support described in paragraph (2); 
(4) a strategy to develop and test risk reduction 
strategies intended to lower the incidence and preva-
lence of amyotrophic lateral sclerosis among vet-
erans; 
(5) a strategy to develop a pathway for veterans 
receiving amyotrophic lateral sclerosis care within 
Department of Veterans Affairs clinics to participate 
VerDate Sep 11 2014 
03:03 Nov 11, 2025
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6001.IH
H6001
kjohnson on DSK7ZCZBW3PROD with $$_JOB
in clinical trials and research sponsored by the De-
partment of Veterans Affairs; and 
(6) any recommendations for the enactment of 
legislation to address the challenges or needs associ-
ated with lowering the incidence and prevalence of 
amyotrophic lateral sclerosis among veterans. 
(b) TRACKING OF AMYOTROPHIC LATERAL SCLE-
ROSIS IN MEMBERS AND VETERANS.—The Secretary of 
Veterans Affairs shall track the prevalence of amyotrophic 
lateral sclerosis in veterans using the amyotrophic lateral 
sclerosis registry and biorepository of the Centers for Dis-
ease Control and Prevention. 
(c) SUBSEQUENT REPORTS.—Not later than three 
years after the date of the enactment of this Act, and 
every three years thereafter, the Secretary of Veterans Af-
fairs shall submit to Congress an update to the report re-
quired under subsection (a) and information on the preva-
lence of amyotrophic lateral sclerosis tracked under sub-
section (b). 
Æ 
VerDate Sep 11 2014 
03:03 Nov 11, 2025
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H6001.IH
H6001
kjohnson on DSK7ZCZBW3PROD with $$_JOB